These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
539 related articles for article (PubMed ID: 7997239)
1. Characterization of gonadal sex cord-stromal tumor cell lines from inhibin-alpha and p53-deficient mice: the role of activin as an autocrine growth factor. Shikone T; Matzuk MM; Perlas E; Finegold MJ; Lewis KA; Vale W; Bradley A; Hsueh AJ Mol Endocrinol; 1994 Aug; 8(8):983-95. PubMed ID: 7997239 [TBL] [Abstract][Full Text] [Related]
2. Follistatin is a modulator of gonadal tumor progression and the activin-induced wasting syndrome in inhibin-deficient mice. Cipriano SC; Chen L; Kumar TR; Matzuk MM Endocrinology; 2000 Jul; 141(7):2319-27. PubMed ID: 10875231 [TBL] [Abstract][Full Text] [Related]
3. Characterization of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: a potential role in autocrine growth regulation. Di Simone N; Crowley WF; Wang QF; Sluss PM; Schneyer AL Endocrinology; 1996 Feb; 137(2):486-94. PubMed ID: 8593793 [TBL] [Abstract][Full Text] [Related]
4. Activin signaling through activin receptor type II causes the cachexia-like symptoms in inhibin-deficient mice. Coerver KA; Woodruff TK; Finegold MJ; Mather J; Bradley A; Matzuk MM Mol Endocrinol; 1996 May; 10(5):534-43. PubMed ID: 8732684 [TBL] [Abstract][Full Text] [Related]
5. Pituitary follistatin and inhibin subunit messenger ribonucleic acid levels are differentially regulated by local and hormonal factors. Bilezikjian LM; Corrigan AZ; Blount AL; Vale WW Endocrinology; 1996 Oct; 137(10):4277-84. PubMed ID: 8828487 [TBL] [Abstract][Full Text] [Related]
6. Regulation of inhibin/activin subunit messenger ribonucleic acids (mRNAs) by activin A and expression of activin receptor mRNAs in cultured human granulosa-luteal cells. Erämaa M; Hildén K; Tuuri T; Ritvos O Endocrinology; 1995 Oct; 136(10):4382-9. PubMed ID: 7664658 [TBL] [Abstract][Full Text] [Related]
7. Presence of activin, inhibin, and follistatin in epithelial ovarian carcinoma. Welt CK; Lambert-Messerlian G; Zheng W; Crowley WF; Schneyer AL J Clin Endocrinol Metab; 1997 Nov; 82(11):3720-7. PubMed ID: 9360531 [TBL] [Abstract][Full Text] [Related]
8. Sex difference in the action of activin-A on cell proliferation of differentiating rat gonad. Kaipia A; Toppari J; Huhtaniemi I; Paranko J Endocrinology; 1994 May; 134(5):2165-70. PubMed ID: 8156918 [TBL] [Abstract][Full Text] [Related]
9. A two-site monoclonal antibody immunoradiometric assay for human follistatin: secretion by a human ovarian teratocarcinoma-derived cell line (PA-1). Wang QF; Khoury RH; Smith PC; McConnell DS; Padmanahban V; Midgley AR; Schneyer AL; Crowley WF; Sluss PM J Clin Endocrinol Metab; 1996 Apr; 81(4):1434-41. PubMed ID: 8636347 [TBL] [Abstract][Full Text] [Related]
10. Regulation of follistatin production by rat granulosa cells in vitro. Shintani Y; Dyson M; Drummond AE; Findlay JK Endocrinology; 1997 Jun; 138(6):2544-51. PubMed ID: 9165047 [TBL] [Abstract][Full Text] [Related]
12. Decay of follicle-stimulating hormone-beta messenger RNA in the presence of transcriptional inhibitors and/or inhibin, activin, or follistatin. Attardi B; Winters SJ Mol Endocrinol; 1993 May; 7(5):668-80. PubMed ID: 7686252 [TBL] [Abstract][Full Text] [Related]
13. Prevention of cachexia-like syndrome development and reduction of tumor progression in inhibin-deficient mice following administration of a chimeric activin receptor type II-murine Fc protein. Li Q; Kumar R; Underwood K; O'Connor AE; Loveland KL; Seehra JS; Matzuk MM Mol Hum Reprod; 2007 Sep; 13(9):675-83. PubMed ID: 17704537 [TBL] [Abstract][Full Text] [Related]
14. Activin regulates betaA-subunit and activin receptor messenger ribonucleic acid and cellular proliferation in activin-responsive testicular tumor cells. Di Simone N; Hall HA; Welt C; Schneyer AL Endocrinology; 1998 Mar; 139(3):1147-55. PubMed ID: 9492049 [TBL] [Abstract][Full Text] [Related]
15. Regulation and actions of Smad7 in the modulation of activin, inhibin, and transforming growth factor-beta signaling in anterior pituitary cells. Bilezikjian LM; Corrigan AZ; Blount AL; Chen Y; Vale WW Endocrinology; 2001 Mar; 142(3):1065-72. PubMed ID: 11181520 [TBL] [Abstract][Full Text] [Related]
17. Direct luteinizing hormone action triggers adrenocortical tumorigenesis in castrated mice transgenic for the murine inhibin alpha-subunit promoter/simian virus 40 T-antigen fusion gene. Rilianawati ; Paukku T; Kero J; Zhang FP; Rahman N; Kananen K; Huhtaniemi I Mol Endocrinol; 1998 Jun; 12(6):801-9. PubMed ID: 9626655 [TBL] [Abstract][Full Text] [Related]
18. Transgenic models to study gonadotropin function: the role of follicle-stimulating hormone in gonadal growth and tumorigenesis. Kumar TR; Palapattu G; Wang P; Woodruff TK; Boime I; Byrne MC; Matzuk MM Mol Endocrinol; 1999 Jun; 13(6):851-65. PubMed ID: 10379885 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of activin-beta A subunit mRNA is associated with decreased activin type II receptor mRNA levels in the testes of alpha-inhibin deficient mice. Trudeau VL; Matzuk MM; Haché RJ; Renaud LP Biochem Biophys Res Commun; 1994 Aug; 203(1):105-12. PubMed ID: 8074643 [TBL] [Abstract][Full Text] [Related]